Scholarly Index
Drew M. Pardoll
Bloomberg (United States); 163,976 total citations; 617 total publications; best world rank #9
Bloomberg (United States)
163,976Total citations
617Total publications
164H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Immunology | Lifetime | 53 | US 34 | 99.91 |
| Oncology | Lifetime | 143 | US 76 | 99.76 |
| Biotechnology | Lifetime | 762 | US 228 | 82.75 |
| Oncology | 2021-2025 | 583 | US 255 | 91.45 |
| Immunology | 2021-2025 | 420 | US 155 | 88.27 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 9 | US 5 | 99.98 |
| Immunotherapy and Immune Responses | Lifetime | 12 | US 8 | 99.97 |
| CAR-T cell therapy research | Lifetime | 14 | US 8 | 99.94 |
| Immune Cell Function and Interaction | Lifetime | 57 | US 39 | 99.91 |
| Cancer Research and Treatments | Lifetime | 48 | US 30 | 99.50 |
| T-cell and B-cell Immunology | Lifetime | 171 | US 105 | 99.64 |
| Virus-based gene therapy research | Lifetime | 659 | US 417 | 98.16 |
| vaccines and immunoinformatics approaches | Lifetime | 174 | US 94 | 97.82 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 488 | US 214 | 97.43 |
| Immune cells in cancer | Lifetime | 732 | US 301 | 96.41 |